Drugs News and Research

RSS

Could drinking tea help manage COVID-19?

Researchers summarized the content of active ingredients in different types of tea, the second most consumed beverage in the world. They also explored the possibility of using tea extracts for coronavirus disease 2019 (COVID-19) prevention and treatment.

17 Jan 2023

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

Researchers investigated the ability of kinetin (N6-furfurylaminopurine, MB-905) to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proliferation in vitro.

17 Jan 2023

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

Expansion of five-year collaboration broadens established Organ-on-a-chip research demonstrating advanced performance of the PhysioMimix MPS.

From CN Bio 17 Jan 2023

Endothelial cell-specific protein Robo4 reduces mortality in severe infection

Pipes play an essential role in bringing water to the faucets in your home, but if one of those pipes springs a leak, damage can result.

16 Jan 2023

New type of CT scan lights up the obvious cause of hypertension

Doctors at Queen Mary University of London and Barts Hospital, and Cambridge University Hospital, have led research using a new type of CT scan to light up tiny nodules in a hormone gland and cure high blood pressure by their removal. The nodules are discovered in one-in-twenty people with high blood pressure.

16 Jan 2023

New molecular pathway critical to the initiation of pancreatic tumors discovered

Researchers at University of California San Diego School of Medicine have discovered a molecular pathway critical to the initiation of pancreatic tumors.

16 Jan 2023

Researchers find a simple way to predict the properties of compounds of drugs with metals

RUDN University chemists, biologists and physicians have found a simple way to predict the properties of compounds of drugs with metals.

16 Jan 2023

Study identifies new tau regulators as viable therapeutic targets for Alzheimer's and other tauopathies

Neurodegenerative diseases affect millions of people worldwide and as our life expectancy increases, more individuals are expected to be affected in the coming decades.

16 Jan 2023

Altering a cellular process can lead stem cells to die or regenerate, study finds

A new study led by Cedars-Sinai and the University of California, San Francisco (UCSF), has determined that altering a cellular process can lead stem cells - cells from which other cells in the body develop - to die or regenerate.

13 Jan 2023

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

Researchers at the University of Colorado Anschutz Medical Campus have discovered a drug combination that may offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer.

13 Jan 2023

Protein discovery could lead to more effective treatments for lymphoma and lung cancer

Scientists from The Australian National University and the Peter MacCallum Cancer Centre have discovered that a protein, called Menin, contributes to abnormal deactivation of specific genes in cancer cells.

13 Jan 2023

What is pharmaceutical forecasting?

In this interview News Medical is talking to David James about pharmaceutical forecasting, J+D Forecasting solutions and their plans for the future.

From J+D Forecasting 13 Jan 2023

California Attorney General sues drugmakers over inflated insulin prices

California Attorney General Rob Bonta on Thursday sued the six major companies that dominate the U.S. insulin market, ratcheting up the state's assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients.

12 Jan 2023

Comprehensive atlas of protein kinases could help scientists decipher many cellular signaling pathways

One of the most important classes of human enzymes are protein kinases - signaling molecules that regulate nearly all cellular activities, including growth, cell division, and metabolism.

12 Jan 2023

Silencing the immune evasion gene enhances cancer cells' susceptibility to immunotherapy

Immune checkpoint inhibitors are important medications that boost the immune system's response against various cancers, but some patients' cancer cells are unaffected by the drugs or develop resistance during treatment.

12 Jan 2023

ADDF-Harrington partnership accelerates the translation of innovative Alzheimer's research into therapies

The Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute at University Hospitals in Cleveland have granted an ADDF-Harrington Scholar Award to Christiane Wrann, PhD, DVM, Associate Professor in Medicine at the Cardiovascular Research Center and the McCance Center for Brain Health at Massachusetts General Hospital and the Harvard Medical School in Boston.

12 Jan 2023

New research identifies natural compounds with pan-SARS-CoV-2 inhibitory activity

Scientists have recently conducted a cell-based high-content screening of over 300 natural compounds and identified three compounds with potent antiviral activities against SARS-CoV-2 and its variants.

12 Jan 2023

How might healthcare transform in the next 50 years?

A new study published in Futures highlighted key factors likely to influence the evolution of medicine over the next 50 years. These factors included wellness technologies, data-driven personalization, and climate change.

12 Jan 2023

Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics that promote remyelination for the treatment of neurological diseases such as multiple sclerosis, announced today it has entered into an exclusive worldwide license agreement with UCB.

12 Jan 2023

New genetic test could guide the treatment of ovarian cancer

Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an effective but expensive medication.

11 Jan 2023

Drugs News and Research

Could drinking tea help manage COVID-19?

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

Endothelial cell-specific protein Robo4 reduces mortality in severe infection

New type of CT scan lights up the obvious cause of hypertension

New molecular pathway critical to the initiation of pancreatic tumors discovered

Researchers find a simple way to predict the properties of compounds of drugs with metals

Study identifies new tau regulators as viable therapeutic targets for Alzheimer's and other tauopathies

Altering a cellular process can lead stem cells to die or regenerate, study finds

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

Protein discovery could lead to more effective treatments for lymphoma and lung cancer

What is pharmaceutical forecasting?

California Attorney General sues drugmakers over inflated insulin prices

Comprehensive atlas of protein kinases could help scientists decipher many cellular signaling pathways

Silencing the immune evasion gene enhances cancer cells' susceptibility to immunotherapy

ADDF-Harrington partnership accelerates the translation of innovative Alzheimer's research into therapies

New research identifies natural compounds with pan-SARS-CoV-2 inhibitory activity

How might healthcare transform in the next 50 years?

Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

New genetic test could guide the treatment of ovarian cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News